ConMed
CNMD
46.56
+0.18
+0.39%
ConMed
US · CNMD
#3018 by market cap
Listed 1970
46.56
+0.18
+0.39%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B+
Momentum strategy signal
Hold
Analyst consensus
Hold
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
2
■ Upgrades■ Downgrades
- 0 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: BofA Securities moved from Hold to Sell on 2026-07-30.
Analyst consensus 3 analysts
Hold
Avg price target 49.50 +6.3%
Price target rangecurrent 46.56
Low49.00
Avg49.50
High50.00
Buy 0%
Hold 100%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-29 | Wells Fargo | -- | Hold | 49.00 |
| 2026-10-29 | Needham | -- | Hold | -- |
| 2026-10-29 | J.P. Morgan | -- | Hold | 50.00 |
| 2026-07-30 | Wells Fargo | -- | Hold | 46.00 |
| 2026-07-30 | Piper Sandler | -- | Hold | 45.00 |
| 2026-07-30 | BofA Securities | -- | Sell | -- |
| 2026-07-30 | Needham | -- | Hold | -- |
| 2026-07-30 | J.P. Morgan | -- | Hold | 45.00 |
| 2026-07-29 | BMO Capital | -- | Hold | 45.00 |
| 2026-07-13 | Needham | -- | Hold | -- |
| 2026-07-13 | J.P. Morgan | -- | Hold | 40.00 |
| 2026-07-11 | Wells Fargo | -- | Hold | 39.00 |
| 2026-07-09 | BMO Capital | -- | Hold | 36.00 |
| 2026-05-18 | BofA Securities | -- | Hold | 40.00 |
| 2026-04-30 | Piper Sandler | -- | Hold | 39.00 |
| 2026-04-30 | Needham | -- | Hold | 35.96 |
| 2026-04-30 | J.P. Morgan | -- | Hold | 40.00 |
| 2026-03-17 | Wells Fargo | -- | Hold | 42.00 |
| 2026-03-17 | Piper Sandler | -- | Hold | 39.00 |
| 2026-01-29 | Piper Sandler | -- | Buy | 55.00 |
| 2026-01-29 | Needham | -- | Hold | -- |
| 2026-01-09 | Piper Sandler | -- | Buy | 55.00 |
| 2026-01-09 | Needham | -- | Hold | -- |
| 2025-12-08 | BofA Securities | -- | Hold | 52.00 |
| 2025-12-05 | BofA Securities | -- | Hold | 52.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-30 | BofA Securities | Hold → Sell | -- |
| 2026-03-17 | Piper Sandler | Buy → Hold | 39.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-28 | After close | ±11.22% | -0.09% (in line) |
| 2026/Q2 | 2026-07-29 | After close | ±8.06% | +8.72% (beat) |
| 2026/Q1 | 2026-04-29 | After close | ±13.35% | +1.95% (in line) |
| 2025/Q4 | 2026-01-28 | After close | ±11.37% | -3.57% (in line) |
| 2025/Q3 | 2025-11-05 | After close | ±8.64% | -0.52% (in line) |
| 2025/Q2 | 2025-07-30 | After close | ±10.57% | +2.01% (in line) |
| 2025/Q1 | 2025-04-30 | After close | ±12.03% | +16.45% (beat) |
| 2024/Q4 | 2025-02-05 | After close | ±11.36% | -8.97% (in line) |
| 2024/Q3 | 2024-10-30 | After close | ±16.88% | +4.57% (in line) |
| 2024/Q2 | 2024-07-31 | After close | ±12.00% | -5.36% (in line) |
| 2024/Q1 | 2024-04-24 | After close | ±9.43% | -11.58% (beat) |
| 2023/Q4 | 2024-01-31 | After close | ±9.12% | -12.38% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
ConMed discussion 0 comments